Irbesartan Sandoz

Irbesartan, the active ingredient in Irbesartan Sandoz, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension and diabetic nephropathy in adult patients. GNH USA supplies Irbesartan Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Irbesartan Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Irbesartan is an antihypertensive agent that works on the renin‑angiotensin‑aldosterone system.

- Hypertension: lowers blood pressure by relaxing vascular smooth muscle. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes. - Heart failure: improves cardiac function and reduces hospitalisation risk.

Irbesartan may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness. - Headache. - Fatigue. - Nasal congestion. - Upper respiratory tract infection. - Diarrhoea.

Serious or Rare Side Effects: - Hyperkalemia. - Acute kidney injury. - Angio‑ema. - Severe hypotension. - Liver enzyme elevations. - Myocardial infarction (rare).

When prescribing Irbes. 5 ​                                                                                                 

- Monitor     ewline -   ewline -    ewline   ewline -  ewline -  ewline

The        ewline  ewline